Enhancement and inhibition of snake venom phosphodiesterase activity by lysophospholipids

FEBS Letters

Volumn 436, Issue 2, 1998, Pages 256-258

  Mamillapalli, Ramanaiah ^a   Haimovitz, Rachel ^a   Ohad, Mazor ^a   Shinitzky, Meir ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cyclic AMP; Cyclic lysophosphatidic acid; Phosphodiesterase; Snake venom

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; PHOSPHODIESTERASE; SNAKE VENOM;

ANIMAL CELL; ARTICLE; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SNAKE;

1-METHYL-3-ISOBUTYLXANTHINE; 3T3 CELLS; ANIMALS; CYCLIC AMP; ENZYME ACTIVATION; KINETICS; LYSOPHOSPHOLIPIDS; MICE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; STRUCTURE-ACTIVITY RELATIONSHIP;

SERPENTES;

EID: 0032475892     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)01142-9     Document Type: Article

References (32)

1. Conti M., Nemoz G., Sette C., Vicini E. Endocr. Rev. 16:1995;370-388.
2. Beavo, J.A. (1988) in: P. Greengard and G.A. Robinson (Eds.), Advances in Second Messenger and Phosphoprotein Research, Vol. 22, Raven Press, New York, pp. 1-38.
3. Kini R.M., Gowda T.V. J. Chromatogr. 291:1984;299-305.
4. Dolapchiev L.B., Vassileva R.A., Koumanov K.S. Biochim. Biophys. Acta. 622:1980;331-336.
5. Bentley J.K., Beavo A.J. Curr. Opin. Cell Biol. 4:1992;233-240.
6. Adams, R.L.P., Knowper, J.T. and Leader, D.P. (1986) in: R.L.P. Adams (Ed.), The Biochemistry of Nucleic Acids, Chapman and Hall, New York, pp. 87-119.
7. Sulkowski E., Laskowski M. Biochim. Biophys. Acta. 240:1971;443-447.
8. Phillips G.R. Biochim. Biophys. Acta. 432:1976;237-244.
9. Stoynov S.S., Bakalova A.T., Dimov S.I., Mitkova A.V., Dolapchiev L.B. FEBS Lett. 409:1997;151-154.
10. Ruzzell W.E., Korana H.G. J. Biol. Chem. 234:1959;2114.
11. Sulkowski E., Bjork W., Laskowski M. Sr. J. Biol. Chem. 238:1963;2477.
12. Bjork W. J. Biol. Chem. 238:1963;2487.
13. Bjork W. Biochim. Biophys. Acta. 89:1964;483.
14. Sawanishi H., Suzuki H., Yamamoto S. aki, Waki Y., Kasugai S., Ohya K., Suzuki N., Miyamoto K., Takagi K. J. Med. Chem. 40:1997;3248-3253.
15. Beavo J.A., Reifsnyder D.H. Trends Pharmacol. Sci. 11:1990;150-155.
16. Nicholson C.D., Challis R.A.J., Shahid M. Trends Pharmacol. Sci. 12:1991;19-27.
17. Tokeshi Y., Nakamura M., Kinjoh K., Sunagava M., Hanashiro K., Kosugi T. Toxicon. 36:1998;53-62.
18. Decker W.W., Bogdan G.M., Garcia R.A., Wollen P., Dart R.C. Toxicon. 36:1998;377-382.
19. Morais J.F., De Freitas M.C.W., Yamaguchi I.K., Dos Santos M.C., Dias da Silva W. Toxicon. 32:1994;725-734.
20. Bailey G.S., Al-Joufi A., Rawat S., Smith D.C. Toxicon. 29:1991;777-781.
21. Salomon Y. Methods Enzymol. 195:1981;22-28.
22. van Dijik M.C., Postma F., Hilkmann H., Jalink K., van Blitterswijk W.J., Moolenaar W.H. Curr. Biol. 8:(7):1998;386-392.
23. Fourcade O., Simon M.F., Viode C., Rugani N., Leballe F., Ragab A., Fournie B., Sarda L., Chap H. Cell. 80:1995;919-927.
24. Tokomura A., Harada K., Fukuzawa K., Tsukatani H. Biochim. Biophys. Acta. 875:1986;31-38.
25. Friedman, P., Haimovitz, R. and Shinitzky, M., submitted for publication.
26. Friedman P., Haimovitz R., Markman O., Roberts M.F., Shinitzky M. J. Biol. Chem. 271:1996;953-957.
27. Liliom K., Murakami-Murofushi K., Kobayashi S., Murofushi H., Tigyi G. Am. J. Physiol. 270:1996;C772-C777.
28. Beavo J.A., Rogers N.L., Crofford O.B., Hardman J.G., Sutherland E.W., Newman E.V. Mol. Pharmacol. 6:1970;597-603.
29. Butcher R.W., Sutherland E.W. J. Biol. Chem. 237:1962;1244-1250.
30. Tu, A.T. (1977) in: A.T. Tu (Ed.), Venoms, Chemistry and Molecular Biology, John Wiley, New York.
31. Lee, C.-Y. (1979) in: Handbook of Experimental Pharmacology, Vol. 52, pp. 87-93, Springer-Verlag, Berlin.
32. Liscovitch, M. (1994) in: M. Liscovitch (Ed.), Signal-Activated Phospholipases, G. Landes Co., Austin, TX, pp. 31-63.